Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Randomized Phase 2 and Phase 3 Studies of the First Triple-Combination Drug. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s159, 2023. DOI: 10.25251/skin.7.supp.159. Disponível em: https://skin.dermsquared.com/skin/article/view/2042. Acesso em: 18 apr. 2025.